Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer

• Status: Recruiting
• Trial end date: 2025-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to evaluate the safety and efficacy of diosmin as adjuvant therapy in treatment of non-bleeding peptic ulcer patients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University

Criteria

Inclusion Criteria:

-. Age 25-65 years old.

• Patients of both gender (male and female).

• Non-bleeding Peptic ulcer Patients (duodenal &gastric) diagnosed by endoscopy.

Exclusion Criteria:

• The presence of other factors that can lead to gastric bleeding other than peptic ulcer.

• Patients with cancerous disease

• Breast-feeding.

• Surgically altered stomach ( bariatric surgery),

• Patient with liver disease.

• Bleeding & perforated peptic ulcer.